1-2 of 2
Charis Eng
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Targeting NANOG and FAK via Cx26-derived Cell-penetrating Peptides in Triple-negative Breast Cancer

Free
Erin E. Mulkearns-Hubert, Emily Esakov Rhoades, Salma Ben-Salem, Rashmi Bharti, Nicole Hajdari, Sadie Johnson, Alex Myers, Iris Nira Smith, Smarajit Bandyopadhyay, Charis Eng, Erinn Downs, Justin D. Lathia, Ofer Reizes
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2024) 23 (1): 56–67.
https://doi.org/10.1158/1535-7163.MCT-21-0783
Published: 03 January 2024
View article titled, Targeting NANOG and FAK via Cx26-derived Cell-penetrating Peptides in Triple-negative Breast Cancer
Open the PDF for Targeting NANOG and FAK via Cx26-derived Cell-penetrating Peptides in Triple-negative Breast Cancer in another window
Includes: Supplementary data
Journal Articles

Activation of AR Sensitizes Breast Carcinomas to NVP-BEZ235's Therapeutic Effect Mediated by PTEN and KLLN Upregulation

Free
Yu Wang, Qi Yu, Xin He, Todd Romigh, Jessica Altemus, Charis Eng
Journal: Molecular Cancer Therapeutics
Series: Author Choice
Mol Cancer Ther (2014) 13 (2): 517–527.
https://doi.org/10.1158/1535-7163.MCT-13-0655
Published: 09 February 2014
View article titled, Activation of AR Sensitizes Breast Carcinomas to NVP-BEZ235's Therapeutic Effect Mediated by PTEN and KLLN Upregulation
Open the PDF for Activation of AR Sensitizes Breast Carcinomas to NVP-BEZ235's Therapeutic Effect Mediated by PTEN and KLLN Upregulation in another window
Includes: Supplementary data